Lucid Diagnostics Q1 Earnings Call Highlights
Key Points - Lucid Diagnostics reported Q1 2026 EsoGuard test volume of 3,177 and revenue of $1.3 million, with volume still above its pre-Medicare target range despite a sequential decline from Q4. - Management said the company remains highly focused on a Medicare local... <